High temperature hydrate inhibitors and methods of use

US10934470B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10934470-B2
Application numberUS-201515769038-A
CountryUS
Kind codeB2
Filing dateDec 18, 2015
Priority dateDec 18, 2015
Publication dateMar 2, 2021
Grant dateMar 2, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Compositions and methods of using of such compositions to, for example, inhibit of the formation of gas hydrate agglomerates are provided. In one embodiment, the methods comprise: introducing a low-dosage hydrate inhibitor additive into a fluid, wherein the low-dosage hydrate inhibitor additive comprises a quaternary or tertiary ammonium cation moiety, a lipophilic tail, and a sulfonate anion moiety; and exposing the low-dosage hydrate inhibitor additive to a temperature above about 200° F.

First claim

Opening claim text (preview).

What is claimed is: 1. A method comprising: introducing a low-dosage hydrate inhibitor additive into a fluid, wherein the low-dosage hydrate inhibitor additive comprises at least one compound having the structural formula: wherein each of R 1 and R 2 is independently a C 1 to C 6 hydrocarbon chain, wherein R 3 is selected from the group consisting of hydrogen and a C 1 to C 6 hydrocarbon chain, wherein R 4 is a C 1 to C 50 hydrocarbon chain, and wherein R 5 is an organic moiety; and exposing the low-dosage hydrate inhibitor additive to at least one temperature above about 200° F., wherein the low-dosage hydrate inhibitor additive does not substantially degrade for up to about 7 days after being substantially continually exposed to at least one temperature of above about 200° F. 2. The method of claim 1 wherein the organic moiety is selected from the group consisting of: an alkyl group, an alkenyl group, an aryl group, an arylalkyl group, an arylalkenyl group, an alkylaryl group, an alkenylaryl group, a heterocyclic group, a hydroxyl group, a carbonyl group, an amine group, and any combination thereof. 3. The method of claim 1 wherein the fluid comprises at least one component selected from the group consisting of: water, a gas, a liquid hydrocarbon, and any combination thereof. 4. The method of claim 1 wherein the low-dosage hydrate inhibitor additive is introduced into a quaternary ammonium cation moiety or a tertiary ammonium cation moiety the fluid through a conduit or an injection point having at least one temperature above about 200° F. and the low-dosage hydrate inhibitor additive is exposed to at least one temperature above about 200° F. in the conduit or the injection point. 5. The method of claim 1 wherein the fluid has at least one temperature above about 200° F. and the low-dosage hydrate inhibitor additive is exposed to at least one temperature above about 200° F. in the fluid. 6. The method of claim 1 wherein the fluid resides within a location selected from the group consisting of: a conduit, a wellbore, a subterranean formation, and a vessel. 7. The method of claim 1 wherein the fluid comprises water and has a water cut of from about 1% to about 65%. 8. The method of claim 1 wherein the fluid comprises water and has a water cut of about 50% or greater. 9. The method of claim 1 wherein the low-dosage hydrate inhibitor additive is introduced in an amount such that the low-dosage hydrate inhibitor additive is present in the fluid in an amount from about 0.1% to about 10% volume based on the water cut of the fluid. 10. The method of claim 1 wherein the water is selected from the group consisting of: brine, deionized water, and any combination thereof. 11. A method comprising: introducing a low-dosage hydrate inhibitor additive into a wellhead of a wellbore penetrating at least a portion of a subterranean formation having at least one temperature above about 200° F., wherein the low-dosage hydrate inhibitor additive does not substantially degrade for up to about 7 days after being substantially continually exposed to at least one temperature of above about 200° F., wherein the low-dosage hydrate inhibitor additive comprises at least one compound having the structural formula: wherein each of R 1 and R 2 is independently a C 1 to C 6 hydrocarbon chain, wherein R 3 is selected from the group consisting of hydrogen and a C 1 to C 6 hydrocarbon chain, wherein R 4 is a C 1 to C 50 hydrocarbon chain, and wherein R 5 is an organic moiety; and allowing the low-dosage hydrate inhibitor additive to contact a fluid in the wellbore. 12. The method of claim 11 wherein the fluid comprises at least one component selected from the group consisting of: water, a gas, a liquid hydrocarbon, and any combination thereof. 13. The method of claim 11 wherein the fluid comprises water and has a water cut of about 50% or greater. 14. The method of claim 11 wherein wellbore has at least one temperature from about 250° F. to about 350° F. 15. A method comprising: introducing a low-dosage hydrate inhibitor additive into a conduit having at least one temperature above about 200° F. and containing a fluid, wherein the low-dosage hydrate inhibitor additive does not substantially degrade for up to about 7 days after being substantially continually exposed to at least one temperature of above about 200° F., wherein the low-dosage hydrate inhibitor additive comprises at least one compound having the structural formula: wherein each of R 1 and R 2 is independently a C 1 to C 6 hydrocarbon chain, wherein R 3 is selected from the group consisting of hydrogen and a C 1 to C 6 hydrocarbon chain, wherein R 4 is a C 1 to C 50 hydrocarbon chain, and wherein R 5 is an organic moiety. 16. The method of claim 15 wherein the fluid comprises at least one component selected from the group consisting of: water, a gas, a liquid hydrocarbon, and any combination thereof. 17. The method of claim 15 wherein the conduit has at least one temperature from about 250° F. to about 350° F.

Assignees

Inventors

Classifications

  • Hydrates inhibition by using well treatment fluids containing inhibitors of hydrate formers · CPC title

  • characterised by the use of specific surfactants · CPC title

  • C09K8/52Primary

    Compositions for preventing, limiting or eliminating depositions, e.g. for cleaning · CPC title

  • using chemical means for preventing or limiting {, e.g. eliminating,} the deposition of paraffins or like substances · CPC title

  • containing surfactants · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10934470B2 cover?
Compositions and methods of using of such compositions to, for example, inhibit of the formation of gas hydrate agglomerates are provided. In one embodiment, the methods comprise: introducing a low-dosage hydrate inhibitor additive into a fluid, wherein the low-dosage hydrate inhibitor additive comprises a quaternary or tertiary ammonium cation moiety, a lipophilic tail, and a sulfonate anion m…
Who is the assignee on this patent?
Halliburton Energy Services Inc, Multi Chem Group Llc
What technology area does this patent fall under?
Primary CPC classification C09K8/52. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).